Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12260
Abstract: Early Post‐Marketing Phase Vigilance (EPPV) is a unique system that encourages reporting of serious adverse reactions for medications newly introduced to Japan. When a once‐monthly paliperidone palmitate formulation (PP1M) was introduced in Japan in 2013,… read more here.
Keywords: baseline risk; paliperidone palmitate; mortality; risk ... See more keywords
Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US Veterans.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2018.07.011
Abstract: PURPOSE The aim of this article was to describe and compare treatment patterns, health care resource utilization (HRU), and health care costs before and after transition in veterans with schizophrenia who were transitioned from paliperidone… read more here.
Keywords: health care; transition; paliperidone palmitate; pp3m ... See more keywords
Paliperidone palmitate: Experience in a community mental health unit
Sign Up to like & getrecommendations! Published in 2017 at "European Psychiatry"
DOI: 10.1016/j.eurpsy.2017.01.1556
Abstract: Introduction There are many jobs that offer advantages of treatment with long-acting injectable in psychosis. Objective To know the changes in the different variables after the start of paliperidone palmitate (PP). Material and method We… read more here.
Keywords: experience community; paliperidone palmitate; community mental; paliperidone ... See more keywords
Efficacy and Quality of Life in Patients with Schizophrenia and Schizoaffective Disorders Treated with Long-acting Paliperidone Palmitate: A Naturalistic Longitudinal Study
Sign Up to like & getrecommendations! Published in 2017 at "European Psychiatry"
DOI: 10.1016/j.eurpsy.2017.02.108
Abstract: Introduction Intramuscular paliperidone palmitate (PP) is a long-acting, atypical antipsychotic for ntramuscular (IM) administration in the treatment of patients with schizophrenia. Objective To study efficacy and quality of life in patients with schizophrenia and schizoaffective… read more here.
Keywords: schizophrenia schizoaffective; long acting; patients schizophrenia; paliperidone palmitate ... See more keywords
Switching to paliperidone palmitate in an outpatient sample: Preliminary results of a 43-month follow-up
Sign Up to like & getrecommendations! Published in 2017 at "European Psychiatry"
DOI: 10.1016/j.eurpsy.2017.02.375
Abstract: Introduction Patients with psychosis are treated in outpatient community clinics during most of their lifetime. Antipsychotic treatments are commonly used in regular clinical practice. However, the non-adherence is one of the main causes of relapses.… read more here.
Keywords: palmitate outpatient; paliperidone palmitate; switching paliperidone; paliperidone ... See more keywords
Comparison of clinical outcomes associated with long-acting injectable antipsychotics in people with psychotic disorders: an electronic case register study
Sign Up to like & getrecommendations! Published in 2017 at "The Lancet"
DOI: 10.1016/s0140-6736(17)30473-7
Abstract: Abstract Background Long-acting injectable (LAI) antipsychotics have been shown to reduce risk of relapse in people with psychosis. Second generation LAI antipsychotics such as paliperidone palmitate can have fewer side-effects and be better tolerated than… read more here.
Keywords: case register; lai; lai antipsychotics; paliperidone palmitate ... See more keywords
Letter to the Editor: Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
Sign Up to like & getrecommendations! Published in 2018 at "Psychological Medicine"
DOI: 10.1017/s0033291718001319
Abstract: © Cambridge University Press 2018. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the… read more here.
Keywords: injectable antipsychotics; effective long; long acting; palmitate effective ... See more keywords
A Review of Current Strategies in Treatment-Resistant Schizophrenia: Considering Paliperidone Palmitate LAI With and Without Olanzapine as an Alternative to Clozapine
Sign Up to like & getrecommendations! Published in 2023 at "CNS Spectrums"
DOI: 10.1017/s109285292300202x
Abstract: Abstract Background Schizophrenia is a debilitating mental illness that affects patient’s function and quality of life. Estimates indicate a lifetime prevalence of 0.48%, causing up to 13.4 million years of life burdened by disability. 30%… read more here.
Keywords: effect; paliperidone palmitate; clozapine; paliperidone ... See more keywords
Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000000827
Abstract: Purpose/Background The study objective was to compare the impact of being treated by paliperidone palmitate (PP) or risperidone long-acting injection (RLAI) on the length of stay on initial hospitalization, rehospitalization risk, and treatment duration in… read more here.
Keywords: risperidone long; long acting; rlai; paliperidone palmitate ... See more keywords
Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000000993
Abstract: Purpose Although schizophrenia can be treated effectively, acute aggravations and relapses occur often. Antipsychotic drug therapies are fairly effective for decreasing the rate of relapses in patients with schizophrenia. This study aimed to compare paliperidone… read more here.
Keywords: second generation; paliperidone palmitate; medication adherence; generation oral ... See more keywords
Tolerability of effective high doses of paliperidone palmitate in patients with severe resistant schizophrenia
Sign Up to like & getrecommendations! Published in 2017 at "International Clinical Psychopharmacology"
DOI: 10.1097/yic.0000000000000151
Abstract: The aim of the study was to evaluate the effectiveness and tolerability of doses of paliperidone palmitate (PP) of 175 mgEq and over/28 days in patients with severe schizophrenia [Clinical Global Impression-Severity scale (CGI-S)≥5] and their… read more here.
Keywords: doses paliperidone; patients severe; paliperidone palmitate; tolerability ... See more keywords